Headline
The latest stories from AHA Today.
CMS’ proposal mandating the disclosure of negotiated charges between health plans and hospitals is the wrong approach, exceeds the Administration's legal authority and should be abandoned, AHA told the agency today.
The AHA today expressed support for the Closing Loopholes for Orphan Drugs Act, H.R. 4538, bipartisan legislation that would limit the “orphan drug” exclusion for 340B Drug Pricing Program rural and cancer hospitals.
The Centers for Medicare & Medicaid Services yesterday proposed surveying hospitals about their acquisition costs for specified covered outpatient drugs under the 340B drug savings program.
The National Institutes of Health yesterday awarded $945 million in fiscal year 2019 funding under its Helping to End Addiction Long-term Initiative for research projects to improve treatments for chronic pain, curb opioid use disorder and overdose rates, and support long-term recovery from opioid…
NYC Health + Hospitals has published a guide to help hospitals and health systems plan and train for emerging infectious disease threats, and customize their plans specific to their unique clinical, operational and financial needs.
More than 1,000 human resource leaders and partners convened this week at the annual conference of the AHA’s American Society for Health Care Human Resources Administration in Chicago.
The Senate today voted 82-15 to approve a continuing resolution that funds the federal government through Nov. 21 and delays impending Medicaid cuts, among other provisions.
Senate Finance Committee leaders yesterday released the statutory text for the Prescription Drug Pricing Reduction Act of 2019 (S-2543), which closely mirrors the chairman’s mark that passed the committee in July.
At an AHA forum today in Denver, hospital and health system leaders shared how they are collaborating with other health care providers, payers, employers and community partners to deliver better care and value to consumers.
The Centers for Disease Control and Prevention today updated the number of people with confirmed or probable lung injuries associated with electronic cigarette use or vaping products to 805 in 46 states and the U.S. Virgin Islands, including 12 deaths.